- Home
- CENN vs COEP Comparison
CENN vs COEP Comparison
Compare CENN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- COEP
- Stock Information
- Founded
- CENN 2013
- COEP 2017
- Country
- CENN United States
- COEP United States
- Employees
- CENN 260
- COEP N/A
- Industry
- CENN Auto Manufacturing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENN Consumer Discretionary
- COEP Health Care
- Exchange
- CENN Nasdaq
- COEP Nasdaq
- Market Cap
- CENN 29.7M
- COEP 27.4M
- IPO Year
- CENN N/A
- COEP N/A
- Fundamental
- Price
- CENN $0.53
- COEP $10.77
- Analyst Decision
- CENN
- COEP
- Analyst Count
- CENN 0
- COEP 0
- Target Price
- CENN N/A
- COEP N/A
- AVG Volume (30 Days)
- CENN 669.4K
- COEP 56.9K
- Earning Date
- CENN 08-12-2025
- COEP 08-15-2025
- Dividend Yield
- CENN N/A
- COEP N/A
- EPS Growth
- CENN N/A
- COEP N/A
- EPS
- CENN N/A
- COEP N/A
- Revenue
- CENN $31,097,533.00
- COEP $62,874.00
- Revenue This Year
- CENN N/A
- COEP N/A
- Revenue Next Year
- CENN N/A
- COEP N/A
- P/E Ratio
- CENN N/A
- COEP N/A
- Revenue Growth
- CENN 234.45
- COEP N/A
- 52 Week Low
- CENN $0.51
- COEP $2.31
- 52 Week High
- CENN $1.70
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- CENN 35.04
- COEP 59.53
- Support Level
- CENN $0.60
- COEP $11.30
- Resistance Level
- CENN $0.65
- COEP $12.71
- Average True Range (ATR)
- CENN 0.04
- COEP 0.89
- MACD
- CENN 0.00
- COEP 0.18
- Stochastic Oscillator
- CENN 27.27
- COEP 54.39
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.